Skip to main content

and
  1. No Access

    Article

    Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

    H Tilly, F Morschhauser, G Salles, R-O Casasnovas, P Feugier, T J Molina in Leukemia (2013)

  2. No Access

    Article

    The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

    Gene expression profiles have been associated with clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with anthracycline-containing chemotherapy. Using Affymetrix HU133A microarray...

    J-P Jais, C Haioun, T J Molina, D S Rickman, A de Reynies, F Berger in Leukemia (2008)

  3. No Access

    Article

    Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

    Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. Th...

    E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, P Felman in Leukemia (2008)

  4. No Access

    Article

    Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin

    A Traverse-Glehen, A Verney, L Baseggio, P Felman, E Callet-Bauchu in Leukemia (2007)

  5. No Access

    Article

    Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases

    The purpose of this study was to document the frequency and distribution of karyotypic changes present at diagnosis in 103 non-MALT marginal zone cell lymphoma (MZL) patients. This cytogenetic analysis of a la...

    E Callet-Bauchu, L Baseggio, P Felman, A Traverse-Glehen, F Berger, D Morel in Leukemia (2005)

  6. No Access

    Article

    FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

    S Camilleri-Broët, N Mounier, A Delmer, J Brière, O Casasnovas, L Cassard in Leukemia (2004)

  7. No Access

    Article

    Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

    With the introduction of new drugs such as alpha-interferon (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, deoxycoformycin (DCF) produced higher complete r...

    F Maloisel, L Benboubker, M Gardembas, B Coiffier, M Divine, C Sebban, M Blanc in Leukemia (2003)

  8. No Access

    Article

    Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis

    C Thieblemont, K Chettab, P Felman, E Callet-Bauchu, A Traverse-Glehen in Leukemia (2002)

  9. No Access

    Article

    A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

    Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

    C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles in Leukemia (2000)

  10. No Access

    Article

    Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma

    Serum lactic dehydrogenase (LDH) is an important prognostic factor in patients with non-Hodgkin’s lymphoma (NHL). We have examined the LDH isoenzyme content in serum and CSF of patients with NHL, at diagnosis ...

    C Dumontet, J Drai, J Bienvenu, E Neidhardt Berard, C Thieblemont, F Bouafia in Leukemia (1999)

  11. No Access

    Article

    Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome

    Unbalanced translocations involving chromosome arm 17p, where the TP53 tumor suppressor gene localizes, are rarely described in chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), but recent...

    E Callet-Bauchu, G Salles, S Gazzo, C Poncet, D Morel, J Pagès, B Coiffier in Leukemia (1999)

  12. No Access

    Article

    Mantle cell lymphoma: a retrospective study of 121 cases

    Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and...

    H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia in Leukemia (1998)